MITA expresses dismay with final CMS ruling on amyloid imaging

10/2/2013 | (free registration)

The Medical Imaging and Technology Alliance expressed disappointment with the limited nature of the CMS' ruling on beta-amyloid PET, which said the agency will only cover a single scan for clinical trial participants under its coverage with evidence development framework. MITA said it will continue to work for broader coverage under Medicare.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI